Sydney-based CRO Southern Star Research can access the financial, operational and regulatory advantages of conducting clinical trials in Australia. This local knowledge, as well as our full-service offering, enables our biotechnology, pharmaceutical and medical device customers to benefit from the Australian environment. We have expertise in a broad range of indications, and a Clinical Team who have an average of 17 years direct clinical research experience. Furthermore, all of our work is underpinned by a passion for cutting edge science, a keen interest in early stage clinical development and a willingness to provide every client with exceptional customer service. With a track record of success in clinical trials spanning Phase I to IV, Southern Star Research has both the capability and the drive to support your R&D objectives in Australia and Asia-Pacific.
Location: Australia, New South Wales, Sydney
Employees: 51-200
Founded date: 2010
Mentions in press and media 3
| Date | Title | Description |
| 14.02.2025 | Navigating the New Frontiers of Clinical Trials and Cybersecurity: Southern Star Research and NSFOCUS Lead the Charge | In the fast-paced worlds of biotechnology and cybersecurity, two companies stand out as beacons of innovation and efficiency: Southern Star Research and NSFOCUS. Both have recently garnered recognition from Frost & Sullivan for their un... |
| 13.02.2025 | Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies | Southern Star sets itself apart in the CRO market through a unique combination of trust, operational advantages, deep industry expertise, and a strong commitment to local resources. SAN ANTONIO, Feb. 13, 2025 /PRNewswire/ -- Frost & Sul... |
| 09.08.2023 | Southern Star Research Adopts Veeva Vault eTMF and Veeva Vault CTMS to Streamline Trial Processes | Full-service CRO uses Veeva Vault Clinical Operations Suite applications for increased efficiency, scalability, and collaboration SYDNEY, AUSTRALIA – Media OutReach – 10 August 2023 – Veeva Systems (NYSE: VEEV) today announced that Southern... |